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With increasing numbers of antibiotic-resistant pathogens all over the world there is a
pressing need for strategies that are capable of inactivating biofilm-state pathogens with
less potential of developing resistances in pathogens. Antimicrobial strategies of that kind
are especially needed in dentistry in order to avoid the usage of antibiotics for treatment
of periodontal, endodontic or mucosal topical infections caused by bacterial or yeast
biofilms. One possible option could be the antimicrobial photodynamic therapy (aPDT),
whereby the lethal effect of aPDT is based on the principle that visible light activates
a photosensitizer (PS), leading to the formation of reactive oxygen species, e.g., singlet
oxygen, which induce phototoxicity immediately during illumination. Many compounds
have been described as potential PS for aPDT against bacterial and yeast biofilms so far,
but conflicting results have been reported. Therefore, the aim of the present review is to
outline the actual state of the art regarding the potential of aPDT for inactivation of biofilms
formed in vitro with a main focus on those formed by oral key pathogens and structured
regarding the distinct types of PS.
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INTRODUCTION
Infections caused by bacterial biofilms are an immediate prob-
lem for public health as—according to the National Institutes
of Health (NIH)—biofilm-associated diseases can be accounted
for 80% of all infections in humans (PA-07-288: Immunology
of Biofilms). According to Rodney M. Donlan and J. William
Costerton the current definition of the term “biofilm” is as
follows:
“A biofilm is a microbially derived sessile community characterized
by cells that are irreversibly attached to a substratum or interface
or to each other, are embedded in a matrix of extracellular polymeric
substances that they have produced, and exhibit an altered phenotype
[as compared to planktonic cells] with respect to growth rate and
gene transcription” (Donlan and Costerton, 2002)
It is well known that the properties of bacteria embedded in
biofilms are very different from those of their planktonic counter-
parts. For example, Shani et al. revealed that the concentrations
of amine fluoride and chlorhexidine, which were able to kill
monospecies biofilms of Streptococcus sobrinus, were about 100
times greater than the concentrations that were necessary to erad-
icate planktonic cultures of the same organism (Shani et al.,
2000). Likewise, Ceri et al. showed that for eradication of biofilms
of Escherichia coli, Pseudomonas aeruginosa, and Staphylococcus
aureus even up to 1000 times higher concentrations of a cer-
tain antibiotic were required for the antibiotic to be effective
compared to planktonic cells (Ceri et al., 1999). The enhanced
tolerance of microorganisms growing in biofilms against antimi-
crobials can be explained as follows:
Firstly, the biofilm matrix—also referred to as EPS (extracel-
lular polymeric substance)—itself may slow drug-diffusion by its
higher viscosity or can even act as a barrier (Mah and O’Toole,
2001; Stewart and Costerton, 2001). For example, EPS-molecules
are able to react with antimicrobials via redox-processes, posi-
tively charged agents bind to negatively charged EPS-molecules
and π-π-interactions of aromatic surfaces are possible, prevent-
ing penetration of the respective drug in deeper parts of the
biofilm (Mah and O’Toole, 2001; Stewart and Costerton, 2001).
Secondly, gene expression is altered between sessile and plank-
tonic cells. Shemesh et al. demonstrated by a comparative tran-
scriptome analysis for Streptococcus mutans that approximately
12% of genes showed a significantly dissimilar expression pat-
tern in sessile and planktonic cells (Shemesh et al., 2007). Welin
and Svensäter showed that in comparison to planktonic cells
protein expression is altered in matured 3 days old biofilms as
well as during the initial stage of biofilm formation; hereby they
found that the expression of proteins related to the carbohy-
drate catabolism was elevated during initial attachment, whereas
in matured biofilms it was reduced (Svensäter et al., 2001; Welin
et al., 2004). Likewise, Lo et al. showed for Porphyromonas gin-
givalis, a periodontal pathogen, that approximately 18% of its
genome was expressed distinctly when the bacterium was grown
as monospecies biofilm; hereby, mainly genes involved in DNA
replication and energy production were downregulated whereas
a number of genes encoding binding and transport proteins were
upregulated (Lo et al., 2009).
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Furthermore, development of a biofilm leads to an enormous
genetic diversity of its cells, which provides “insurance” for the
cells for better adaption to abrupt alteration of environment con-
ditions (Kolter and Greenberg, 2006). Boles et al. showed for
Pseudomonas aeruginosa that biofilm-grown cells had varying
colony morphologies when plated on agar, whereas planktonic-
grown cells had not; analyzing these biofilm-grown variants
revealed that they differed notably in their biofilm building and
detachment properties, susceptibility to oxidative stress and other
properties (Boles et al., 2004). Likewise, so-called persister cells
are being formed, when bacteria grow as a biofilm. These are
in a dormant, non-dividing state and provide tolerance toward
antimicrobial agents. This tolerance might function by prevent-
ing target corruption by an antimicrobial due to blocking of the
target (Lewis, 2007). In contrast, resistance means target modi-
fication by mutation or enzymatic changes, target substitution,
destruction or modification of the antibiotic, emergence of efflux
pumps or restricted permeability for antibiotics through cell walls
(Lewis, 2007).
To date, resistances of bacteria against antibiotics (Rossolini
and Mantengoli, 2008) and antimicrobials like chlorhexidine
(CHX) (Yamamoto et al., 1988) and triclosan (Yazdankhah et al.,
2006) are arising and there is a pressing need for develop-
ment of new antimicrobial approaches to fight biofilm infections.
In January 2009, Cesar A. Arias and Barbara E. Murray pub-
lished an article in the New England Journal of Medicine, where
they warned that bacteria might even become winners of evo-
lution since several strains have already adapted toward antibi-
otic and antimicrobial treatment that they become more and
more resistant to conventional therapies; thus, they announced
that this will be a “clinical super-challenge in the 21st cen-
tury” fighting the spread of resistance (Arias and Murray,
2009).
With respect to the situation in the oral cavity, dentists also are
often faced with the situation that they have to combat antibiotic-
resistant bacteria in periodontal (Rams et al., 2014) or endodontic
(Al-Ahmad et al., 2014) infections. For this reason,—in addition
to promoting an adequate and rationalized use of antimicrobials
(Leung et al., 2011)—there is immediate and continual research
in human and dental medicine for alternative methods with less
potential of development of resistances in pathogens. Multi-target
processes are needed in contrast to those of antibiotics, which act
very specific toward one explicit target according the so-called
key-hole principle (Alves et al., 2014).
One of the most promising approaches to overcome the
aforementioned shortcomings is the antimicrobial Photodynamic
Therapy (aPDT). Its antimicrobial effect is based on an oxida-
tive burst upon illumination and relies on damage to cellular
structures and biomolecules, therefore being an unspecific mech-
anism (Maisch et al., 2011). aPDT needs the presence of three
components, (I) a per se non-toxic dye, the so-called photosen-
sitizer (PS), (II) visible light of an appropriate wavelength, and
(III) molecular oxygen. The absorption of light by the PS leads to
a transition to its triplet state, whereupon there are two mecha-
nisms of reaction to let the PS regain its ground state: In type I
mechanism, charge is transferred to a substrate or to molecular
oxygen generating reactive oxygen species like hydrogen peroxide
and oxygen radicals like superoxide ions or free hydroxyl radicals.
In type II mechanism, energy only—not charge—is transferred
directly to molecular oxygen, whereby the highly reactive sin-
glet oxygen (1O2) originates (Wainwright, 1998; Schweitzer and
Schmidt, 2003) (see Figure 1). Hereby, the singlet oxygen quan-
tum yield  describes the fraction of type II mechanism
(Maisch et al., 2007).
In general, a PS used for aPDT should show the following fea-
tures in order to have a pronounced antimicrobial efficacy and
low toxicity toward mammalian cells:
• High 1O2 quantum yield  (Maisch et al., 2007).
• High binding affinity for microorganisms (positively charged
PS for good adherence to negatively charged bacterial cell walls)
(Alves et al., 2009).
FIGURE 1 | Type I and type II processes of aPDT. Visible light of an
appropriate wavelength is absorbed by the PS molecule by what the PS
changes from its initial ground state S0 to an energetically excited state S1.
Thereupon the PS is able to transition within the molecule from its singlet to
its triplet state T1 (inter-system crossing). This T1 state is long-living
compared to S1 so that charge (type I) or energy (type II) can be transferred
to surrounding molecules such as oxygen with emergence of oxygen radicals
(type I) or singlet oxygen (type II).
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• Low binding affinity for mammalian cells (Soukos and
Goodson, 2011).
• Low chemical toxicity andmutagenicity (Soukos and Goodson,
2011).
The efficacy of many PS has already been evaluated for inacti-
vation of biofilms grown in vitro: mainly there were used phe-
nothiazinium dyes, such as Methylene Blue and Toluidine Blue,
tetrapyrrolic macrocycles like porphyrins (e.g., TMPyP) or xan-
thene dyes like Erythrosine and Rose Bengal (RB). In addition,
further chemical classes, e.g., functionalized fullerenes (Mizuno
et al., 2011) or curcumin (Araújo et al., 2012, 2014) were pre-
sented. More recently a dye named SAPYR was introduced, which
is based on a perinaphthenone structure (Cieplik et al., 2013b).
The aim of the present review is to outline the actual state of
research concerning the effect of the photodynamic process for
inactivation of bacterial and yeast biofilms in vitro with a main
focus on aPDT against biofilms grown from oral key pathogens.
aPDT AGAINST BIOFILMS IN VITRO
In the following, only publications were included that investigated
the efficacy of aPDT against bacterial and yeast biofilms grown
in vitro. For ensuring better comparability, only studies were
included, where the effect of aPDT was examined by performing
colony forming unit (CFU) assays. CFU assay data is essential for
evaluating a new antimicrobial approach, as the American Society
of Microbiology (ASM) stated in 2010 that every new approach
has to prove an efficacy of 3 log10 reduction of CFU before being
able to use the terms “antimicrobial” or “antibacterial.”
PHENOTHIAZINIUM DERIVATIVES
The first phenothiazinium dyes were synthetized by the end of the
19th century in Germany in the context of a booming German
textile industry. Hereby, Alizarin, which was developed in 1868
by Carl Graebe and Carl Liebermann, worked as some kind of
precursor, when further research in the purpose of its manufac-
ture and commercialization led to the development of new dyes
(López-Muñoz et al., 2005). One of these new dyes was so-called
“Methylene Blue (MB)”—the first phenothiazinium dye—whose
synthesis protocol was patented by Heinrich Caro in the 1870s
(Caro, 1878).
Besides other applications, e.g., anti-malarial drugs or antipsy-
chotic agents, phenothiazinium derivatives have been employed
as PS due to their strong absorption in the red spectral region
(ca. 600–680 nm) (Felgenträger et al., 2013). Phenothiazinium
dyes are single positively charged and composed of a three-
ring π-system with attached auxochromic side groups, whereby
their singlet oxygen quantum yield  is around 0.5, thus act-
ing according to type I and type II mechanisms (Wilkinson
et al., 1993). Examples for phenothiazinium dyes, which have
been tested for inactivation of biofilms in vitro, are fore-
said MB [3,7-bis(dimethylamino)-phenothiazin-5-ium chloride]
or Toluidine Blue [TBO; 3-amino-7-(dimethylamino)-2-methyl-
phenothiazin-5-ium chloride] (see Figure 2).
Using MB, Fontana et al. investigated its effect on ex vivo
polymicrobial biofilms cultivated from dental plaque samples
taken from patients with chronic periodontitis. After a cultivation
FIGURE 2 | Phenothiazinium derivatives. Chemical structures of
phenothiazinium derivatives: (A) Methylene Blue. (B) Toluidine Blue. (C)
Safranine O.
period of 7 days, the biofilms were incubated with MB in con-
centrations of 25 or 50μg/ml for 5min and illuminated with a
diode laser (1W; 665 nm) for another 5min, whereby a light dose
of 30 J/cm2 was applied, which resulted in a maximal inactiva-
tion rate of 32 % CFU only. The authors concluded that this low
susceptibility of complex dental biofilms toward aPDT may be
overcome by novel delivery and targeting approaches (Fontana
et al., 2009).
For testing the efficacy of MB on yeast biofilms, Rossoni et al.
(2014) cultured biofilms of Candida albicans serotype A and B
strains for 48 h. After that period, biofilms were incubated with
MB at a concentration of 300μM for 5min and subsequently
irradiated with a gallium-aluminum-arsenide (GaAlAs) laser
(35mW; 660 nm) for 285 s, applying a light dose of 26.3 J/cm2.
This resulted in reductions of less than 1 log10 (64%) for serotype
A biofilms, whereas for serotype B biofilms there was a reduction
of more than 2 log10. The authors explained these distinct inacti-
vation rates of Candida albicans serotype A and B biofilms by the
differences in cell wall mannan structure between both serotypes.
Furthermore, this difference in sensitivity to aPDT may be due
to ultrastructural differences in EPS composition (Rossoni et al.,
2014). However, in a comment to this study Mariusz Grinholc
opposed that (i) only single reference strains of both serotypes
and (ii) only one PS were tested, wherefore it may not be possi-
ble to conclude a general serotype-dependent sensitivity toward
aPDT in cells of Candida albicans (Grinholc, 2014).
Employing TBO as a PS, the Brazilian group of Iriana C. J.
Zanin conducted a number of studies (Zanin et al., 2005, 2006;
Teixeira et al., 2012): In 2005 they examined its antimicrobial
effect in combination with either a helium/neon (HeNe) gas laser
(32mW; 632.8 nm) or a light-emitting diode (LED; 32mW; 620–
660 nm with a maximum at 638.8 nm) on Streptococcus mutans
www.frontiersin.org August 2014 | Volume 5 | Article 405 | 3
Cieplik et al. aPDT against biofilms in vitro
biofilms grown on hydroxyapatite discs in a constant-depth film
fermentor for 3, 7, or 10 days. After the respective culture period
biofilms were incubated with TBO (100mg/l) for 5min and
afterwards irradiated for 5, 15, or 30min with HeNe laser or
LED light (light doses of 49, 147, or 294 J/cm2). This resulted
in reductions in viability of CFU of 2 to 5 log10 steps depend-
ing on biofilm age, light source and irradiation period (Zanin
et al., 2005). One year later, they tested the effect of TBO and
LED light on monospecies biofilms of Streptococcus mutans,
Streptococcus sobrinus, and Streptococcus sanguinis. Here, biofilms
were cultivated for 5 days on enamel slabs. After incubation
with TBO (100mg/l) for 5min, biofilms were exposed to LED
light (32mW; 620–660 nm, maximum: 638.8 nm) for 7min (light
dose: 85.7 J/cm2). Results showed inactivation rates of approx-
imately 1 log10 step for Streptococcus mutans and Streptococcus
sobrinus biofilms and more than 3 log10 for Streptococcus sangui-
nis biofilms. The authors tried to explain these varying results
by the ability of mutans streptococci like Streptococcus mutans
and Streptococcus sobrinus to produce EPS to a greater extent
than Streptococcus sanguinis, which is not among mutans strep-
tococci (Zanin et al., 2006). In 2012, the same group published
a combined in vitro and in situ report on the photodynamic
effect of TBO: (i) biofilms of Streptococcus mutans were grown
on hydroxylapatite discs for 5 days, (ii) volunteers wore intraoral
devices with enamel slabs for 7 days under cariogenic challenge
by dropping a sucrose solution 8 times per day. After the respec-
tive culture period biofilms were incubated with TBO (100mg/l)
for 5min and irradiated with a LED light source (40mW, 620–
660 nm, maximum: 638.8 nm) for 15min (light dose 55 J/cm2).
For in vitro biofilms CFU were reduced by more than 5 log10 steps
after aPDT, whereas for in situ biofilms reduction was less than
1 log10 step, when the numbers of CFU of Streptococcus mutans
and total streptococci were examined. These distinct results were
explained by the authors due to the thickness of the referring
biofilms with in situ biofilms (1000μm) being approximately
tenfold as thick as in vitro biofilms (100μm); therefore, they con-
cluded that this problem could be solved e.g., by developing a PS
being able to penetrate through the EPS (Teixeira et al., 2012).
As MB and TBO are designated to be potential efflux pump
substrates in a variety of microbial species (Tegos and Hamblin,
2006; Prates et al., 2011) and due to the enhancing effect of efflux
pump inhibitors on photodynamic inactivation of planktonic
cells of Gram positives (Tegos et al., 2008), Kishen et al. (2010)
tested the potentiating effect of an efflux pump inhibitor (ver-
apamil hydrochloride) on aPDT with MB against Enterococcus
faecalis monospecies biofilms. Hereby, 4 days old biofilms were
incubated with MB or anionic RB (see below, Chapter Eosin Y,
Erythrosine, Rose Bengal) as a control PS at concentrations of
100μM for 15min in the dark and subsequently irradiated with
a noncoherent light source with 30 nm bandpass filters (300–
600mW; MB: 660 ± 15 nm; RB: 540 ± 15 nm), employing light
doses from 10 to 40 J/cm2. For MB, there was a killing efficacy of
more than 5 log10 steps, which could even be enhanced slightly
by an additional incubation with the efflux pump inhibitor.
Employing RB exhibited onlymarginally worse results (≈5 log10).
However, CLSM analysis showed that aPDT with these PS had
different effects on the Enterococcus faecalis biofilms: While aPDT
with RB produced no substantial destruction of biofilm structure,
aPDT with MB resulted in damage of biofilm structure to a
greater extent (Kishen et al., 2010).
In a study investigating the efficacy of two commercially avail-
able systems for aPDT, Meire et al. (2012) treated 24 h old
biofilms of Enterococcus faecalis either with PAD™ (Dentofex,
Inverkeithing, UK) or HELBO® (HELBO® Photodynamic
Systems, Bredent medical, Senden, Germany) according to the
recommendations of the manufacturers. For PAD™, biofilms
were incubated for 2min with TBO at a concentration of
12.7mg/l and afterwards illuminated for 150 s with a soft diode
laser (100mW) emitting at 635 nm. For HELBO®, incubation of
the Enterococcus faecalis biofilms was with MB (10mg/ml) for
3min with a subsequent irradiation for 2min with a soft laser
(HELBO® Theralite Laser) obtaining a wavelength of 660 nm and
an output-power of 75mW. Results showed a 2 log10 step reduc-
tion for HELBO®, whereas PAD™ exhibited only an inactivation
rate of less than 1 log10 step. When in addition the antibacterial
efficacy of irradiation with Er:YAG (2940 nm; 50 or 100mJ; 15Hz;
40 s) and Nd:YAG (1064 nm; 2W; 15Hz; 40 s) lasers was tested,
there was a 4 log10 inactivation rate for Er:YAG treatment using
100mJ pulses, whereas Er:YAG using 50mJ pulses and Nd:YAG
had no effect at all (<1 log10). In contrast, treatment with NaOCl
(2.5%; 1, 5, 10, or 30min) showed reductions ofmore than 6 log10
regardless which immersion periods were used. However, a pro-
longed action of NaOCl beyond the respective treatment periods
cannot be ruled out, since no reagent was used for stopping its
antimicrobial effect after the respective immersion period (Meire
et al., 2012).
However, in addition to the above-mentioned batch-culture
studies, phenothiazinium derivatives have also been examined
in more applied models: Zand et al. (2014) used extracted
human maxillary and mandibulary incisors, decoronated them
and instrumented their root canals up to #60 K-file. After an
autoclavation process Enterococcus faecalis biofilms were formed
in these root canals for 4, 6 or 8 weeks. Subsequently, canals
were incubated with TBO (25μg/ml) for 5min and irradiated
with a 625 nm diode laser (100mW; light dose 214.28 J/cm2)
twice for 2.5min intermitted by a 2.5min break, applying a total
of 2 × 15 J, which led to a complete elimination of Enterococcus
faecalis below detection limit of the CFU assay (Zand et al.,
2014).
In contrast, Fimple et al. (2008) investigated the photo-
dynamic effects of MB on multispecies biofilms comprising
Actinomyces israelii, Fusobacterium nucleatum, Prevotella inter-
media, and Porphyromonas gingivalis in infected root canals of
extracted human teeth. Teeth were decoronated, instrumented
up to an apical file size of 0.465, autoclaved and infected with
the foresaid pathogens. After a culture period of 3 days canals
were incubated with MB (25μg/ml) for 10min and irradiated
by means of a diode laser (1W; 665 nm) coupled to an opti-
cal fiber for 2.5min followed by a 2.5min break and a second
light exposure of 2.5min, applying a total light dose of 30 J/cm2.
Results showed a CFU reduction by 80%. The authors concluded
that aPDT with MB could be an effective adjunct to conven-
tional endodontic treatment, when the parameters get optimized
(Fimple et al., 2008).
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Up to date, phenothiazinium derivatives have to be regarded
as the most studied PS in respect of inactivation of biofilms.
Moreover, recently Voos et al. (2014) examined Safranine O
(3,7-diamino-2,8-dimethyl-5-phenyl-phenazinium chloride), a
structure analog to classical phenothiazinium dyes, where a nitro-
gen atom replaces the sulfur atom, which centers the delocalized
electron system, for aPDT against biofilms. In this study, ex vivo
biofilms were cultured from subgingival plaque samples for 24
or 72 h. After the respective incubation period the biofilms were
incubated with Safranine O (10μM) for 15min followed by
irradiation with a diode laser (0.5W; 532 nm) for 40 or 100 s,
applying light doses of 20 or 50 J/cm2, respectively. In 24 h old
biofilms there was a reduction of 2 log10 steps with a light dose of
20 J/cm2 and 3 log10 steps with 50 J/cm2, whereas treatment with
CHX (0.2%; 3min) generated a reduction by 1 log10 step only.
In contrast, in 72 h old biofilms neither aPDT nor treatment with
CHX led to any antibacterial effect (Voos et al., 2014) (Please find
a summary of all studies described in this section in Table 1).
PORPHYRINS, CHLORINS, AND PHTHALOCYANINES
Porphyrins, chlorins, and phthalocyanines are structurally com-
parable heterocyclic macrocycles, whereby porphyrins and
phthalocyanines are composed of four pyrrole subunits, while
chlorins comprise three pyrrole cycles and one pyrroline (see
Figure 3). Many of these compounds are naturally occurring.
For example, one of the widest known porphyrins is heme, the
pigment in erythrocytes, on which the red color of blood is
based. Likewise, some bacterial species form porphyrins in their
metabolism.
Oral bacteria that are able to synthetize for example black-
pigmented species like Porphyromonas gingivalis and Prevotella
spp. (Soukos et al., 2005; Lennon et al., 2006) or Aggregatibacter
actinomycetemcomitans (Cieplik et al., 2013a). Consequently, it
has been shown in vitro that these bacterial species can be
inactivated by irradiation with light only, whereby it is a com-
monly accepted hypothesis that endogenous porphyrins among
other substances may act as PS and lead to a lethal auto-
photosensitization process (König et al., 2000; Soukos et al., 2005;
Lennon et al., 2006; Cieplik et al., 2013a). Porphyrins and chlorins
have an intense absorption maximum at approximately 405 nm,
known as Soret band, and smaller peaks at wavelengths longer
than 500 nm (Q bands) (Gouterman, 1961); their singlet oxygen
quantum yields are in a range between 0.5 and 0.8 (Fernandez
et al., 1997), thus acting predominantly according to type II
mechanism.
There are some studies evaluating the efficacy of cationic
PS being based on porphyrin or chlorin structures concern-
ing the inactivation of biofilms. With respect to porphyrins,
TMPyP [5,10,15,20-tetrakis(1-methyl-4-pyridinium)-porphyrin
tetra-(p-toluenesulfonate]—a fourfold positively charged
derivative—has to be regarded as the most commonly used PS
(Di Poto et al., 2009; Collins et al., 2010; Maisch et al., 2012;
Cieplik et al., 2013b; Eichner et al., 2013; Gonzales et al., 2013).
Di Poto et al. (2009) cultured biofilms from three distinct strains
of Staphylococcus aureus for 24 h, incubated them with TMPyP at
a concentration of 10μM for 15min and irradiated them with
increasing doses of white light (150–200 J/cm2) isolated from
FIGURE 3 | Porphyrin and chlorin derivatives. Chemical structures of
porphyrin and chlorin derivatives: (A) TMPyP. (B) XF-73. (C)
Photodithazine®.
the emission of a tungsten lamp (166mW/cm2; 400–800 nm),
whereby this treatment exhibited a rate of bacteria killing of 1 to
2 log10 steps at the highest light dose depending on the strain,
which was tested. Hereby, CLSM analysis showed the presence
of dead cells throughout the biofilm implying that there was no
hindrance for the PS to diffuse into the biofilms; consequently,
the authors suggested that the reduced susceptibility of biofilm
bacteria compared to that, which was observed when planktonic
bacteria were treated (≥6 log10), may be due to differences in
cell wall composition, growth rate or EPS-components hindering
uptake of the PS through the cell walls. Furthermore, aPDT dis-
played a second anti-biofilm mechanism in this study leading to
detachment of parts of the biofilm and therefore to a disruption
of biofilm architecture (Di Poto et al., 2009).
Collins et al. (2010) tested the effect of aPDT with TMPyP on
Pseudomonas aeruginosa biofilms, which were cultured for 24 h
from awild type or amutant strain, respectively. After that period,
225μM TMPyP was applied, immediately followed by illumina-
tion with a mercury vapor lamp fitted with a colored glass filter
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blocking wavelengths shorter than 400 nm (100W; ≥400 nm) for
10min (220–240 J/cm2), which resulted in a pronounced inacti-
vation rate of about 4 log10 steps for both strains. In addition,
CLSM analysis revealed that aPDT resulted in substantial disrup-
tion of wild-type biofilms, whereby TMPyP without irradiation
did not have that effect (Collins et al., 2010).
In contrast, when our group used TMPyP for aPDT against
monospecies biofilms of Enterococcus faecalis (as a control PS
for evaluating the antibacterial efficacy of SAPYR, which will be
discussed below) we found no reduction of CFU at all. In this
study, after a cultivation period of 72 h, biofilms were incubated
with TMPyP (100μM) for 60min and irradiated for 2min with
a LED light-curing unit for dental resins (1360mW/cm2; 460 ±
20 nm), whereby the intensity of light reaching the biofilms was
600mW/cm2. This inefficacy may be due to the large molecu-
lar structure of TMPyP, which may hinder the penetration of this
PS throughout the EPS due to steric reasons. Furthermore, drug
diffusion may also be delayed due to strong electrostatic interac-
tions between fourfold positively charged TMPyP and negatively
charged EPS-molecules. The emission of the LED light-curing
unit was also not ideal for excitation of either SAPYR or TMPyP;
nevertheless, this type of light source was chosen, as it is widely
applied in dental practice (Cieplik et al., 2013b).
Pereira Gonzales et al. (2013) compared the antimicrobial
efficacy of XF-73 [5,15-bis-[4-(3-trimethylammoniopropyloxy)-
phenyl]-porphyrin chloride]—a porphyrin derivative with two
positive charges only—to that of TMPyP for inactivation of
Candida albicans biofilms. These biofilms were cultured for 24 h,
incubated with increasing concentrations of PS for 4 h and illu-
minated with an incoherent light source (13.4mW/cm2; 418 ±
20 nm) for 60min, whereby a light dose of 48.2 J/cm2 was applied.
Results showed CFU reductions of more than 5 log10 for con-
centrations of 1.0μM of XF-73 at least, whereas for TMPyP con-
centrations of 50μMwere needed at the minimum for obtaining
equal antimicrobial results. This was explained due to stronger
electrostatic interactions of TMPyP with the EPS compared to
XF-73 leading to a lower degree of diffusion of the PS into the
biofilm (Gonzales et al., 2013).
Referring to chlorins, Photodithazine® is a commercially avail-
able cationic chlorin-e6 derivative with two absorption maxima
at around 400 nm (Soret band) and 660 nm (slightly smaller peak,
Q-band), which has been evaluated in two studies conducted
by the group of Ana C. Pavarina (Dovigo et al., 2013; Quishida
et al., 2013): Quishida et al. formed multispecies biofilms from
Streptococcus mutans, Candida albicans and Candida galbrata
for 48 h; afterwards they were incubated with Photodithazine®
at concentrations from 100 to 250mg/l for 20min and exposed
to red light from a LED light source (71mW/cm2; 660 nm)
for 9min (light dose 37.5 J/cm2). At a PS-concentration of
200mg/ml aPDT-treatment showed reductions of 1 or 2 log10
steps for Candida spp. or Streptococcus mutans, respectively
(Quishida et al., 2013). In another study from the same group,
Dovigo et al. cultured monospecies biofilms of clinical isolates
of Candida spp. according to the protocol outlined above. These
were incubated with Photodithazine® (125mg/l) for 20min and
afterwards illuminated with a LED device (25mW/cm2; 660
± 20 nm) applying a light dose of 37.5 J/cm2. Results showed
reductions of approximately 1 log10 step (Dovigo et al., 2013).
However, in both of these studies Photodithazine® was excited
by red light at its minor absorption peak at 660 nm without this
point being discussed by the authors. Consequently, irradiation
with blue light at 400 nmmay lead to better results (Dovigo et al.,
2013; Quishida et al., 2013).
In contrast to porphyrins and chlorins, phthalocyanines are
highly hydrophobic, which compromises their water solubil-
ity (Ribeiro et al., 2013b). Therefore, methods for solubiliza-
tion of phthalocyanines are mandatory for applying these com-
pounds as PS for aPDT, whereby one option is their entrapment
in nanoemulsions. Ribeiro et al. evaluated chloro-aluminum
phthalocyanine (ClAlPc) encapsulated in cationic and anionic
nanoemulsions (final concentration of ClAlPc in nanoemul-
sions: 31.8μM) in two studies regarding its aPDT-efficacy on
biofilms of Candida albicans (Ribeiro et al., 2013a,b). However,
in these studies the antimicrobial efficacy was only examined
by detecting metabolic cell activity with XTT reduction assay.
Consequently, this data is not comparable to CFU-assay data,
which is mandatory, since—according to the ASM—any novel
approach has to accomplish a CFU reduction rate of more than 3
log10 in order to use the terms “antibacterial” or “antimicrobial”
(Table 2).
EOSIN Y, ERYTHROSINE, ROSE BENGAL
Eosin Y, Erythrosine and Rose Bengal (RB) are anionic xanthene
dyes derived from fluorescein. Hereby, Eosin Y and Erythrosine
are red dyes resulting from the action of either bromine or iodine
on fluorescein, whereas RB is a pink dye eventuating from a
tetrachlorination of Erythrosine (see Figure 4). All these dyes
show intense absorption bands in the green wavelength range
(480–550 nm) (DeRosa and Crutchley, 2002); their singlet oxygen
quantum yields are between 0.6 and 0.8, therefore mainly acting
according to type II mechanism (Wilkinson et al., 1993).
Employing Erythrosine (ERY; 2,4,5,7-tetraiodofluorescein) as
a PS for aPDT, Wood et al. (2006) studied its effect on 200μm
thick biofilms of Streptococcus mutans, which were grown for
up to 288 h in a constant-depth film fermentor, and compared
it to MB and Photofrin, a Porphyrin derivative. The biofilms
were incubated with 22μM ERY, MB, or Photofrin for 15min
and exposed to white light from a tungsten filament lamp
(ERY: 22.7mW/cm2 in the wavelength range 500–550 nm; MB,
Photofrin: 22.5mW/cm2 at 600–650 nm) for 15min. Hereby,
ERY-mediated aPDT resulted in a reduction of about 3 log10 steps
for 288 h old biofilms, whereas aPDT with MB and Photofrin
showed only 2.6 or 1.1 log10 steps inactivation, respectively.
Contrary to expectations, 48 h old biofilms were less suscep-
tible to aPDT, regardless which PS was used (ERY: 2.2 log10;
MB: 1.5 log10; Photofrin: 0.5 log10). The authors explained this
as young biofilms may be more metabolically active, thus hav-
ing more effective repair systems. Moreover, older biofilms may
contain voids and channels through the EPS, allowing greater
amount of penetration of the respective PS (Wood et al., 2006).
However, negatively charged ERY being the most effective PS in
this study is quite contradictory to the above-mentioned general
opinion, how a “perfect” PS should be composed, as the positive
charge of a PS appears to promote an electrostatic interaction
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FIGURE 4 | Fluorescein derivatives. Chemical structures of fluorescein
derivatives: (A) Eosin Y. (B) Erythrosine. (C) Rose Bengal. (D)
Chitosan-conjugated Rose Bengal.
with negatively charged sites at the outer membrane of bacte-
rial cells (Maisch et al., 2004). In contrast, anionic fluorescein
derivatives like ERY or RB may be efficient though due to their
high lipophilicity. In another study of the same group, Metcalf
et al. (2006) investigated the effect of light-fractionation on
aPDT with ERY on Streptococcus mutans biofilms formed under
equal experimental parameters. ERY was used at 22μM with a
15min incubation period, too. Biofilms were illuminated with
the same tungsten filament lamp (22.7mW/cm2; 500–550 nm),
whereby a light dose of 6.75 J/cm2 was applied for every 5min
of irradiation. Here, it was shown that aPDT with ERY can be
potentiated by light fractionation: Streptococcus mutans could
be inactivated by about 2 log10 steps, when ERY was irradi-
ated continuously for 5min, whereas rates of 3 log10 and 3.7
log10 could be achieved, when there were either 5 × 1min light
pulses with 5min recovery periods or 10 × 30 s light pulses
with 2min recovery breaks between pulses. This was explained
by the authors due to replenishment of target molecules such
as oxygen for the PS during the dark periods (Metcalf et al.,
2006).
In order to compare the photodynamic efficacy of ERY and
RB (4,5,6,7-tetrachloro-2′,4′,5′,7′-tetraiodofluorescein), Pereira
et al. (2013) cultured biofilms of Streptococcus mutans and
Streptococcus sanguinis for 48 h and incubated them with either
with ERY or RB at concentrations of 5μM for 5min followed
by irradiation with a blue LED (200mW; 455 ± 20 nm) for
180 s (light dose: 95 J/cm2; applied energy: 36 J). This treatment
exhibited small effects of less than 1 log10 for both species regard-
less of whether ERY or RB was used. However, it has to be
considered that blue light from a 455 nm LED may not be opti-
mal for excitation of ERY and RB with green light being more
appropriate (Pereira et al., 2013). In a study from the same
group, Freire et al. (2013) compared RB with Eosin Y (2,4,5,7-
tetrabromofluorescein) concerning their potency for inactivation
of Candida albicans biofilms. After culturing these biofilms for
48 h, treatment was done with 200μMRB or Eosin Y for 5min as
a pre-irradiation period and subsequent illumination with a green
LED (90mW; 532±10 nm) for 180 s (light dose: 42.63 J/cm2;
applied energy: 16.2 J), which resulted in inactivation rates of
0.22 and 0.45 log10 for RB and Eosin Y, respectively (Freire et al.,
2013). In contrast to those results, Kishen et al. achieved a high
killing efficacy of approximately 5 log10 steps, when using RB
against Enterococcus faecalis monospecies biofilms, as mentioned
above (see Chapter Phenothiazinium Derivatives) (Kishen et al.,
2010).
However, as cationic PS are needed for good antimicro-
bial photodynamic activity, the group of Annie Shrestha and
Anil Kishen synthesized a polycationic chitosan-conjugated Rose
Bengal (CSRB) for mounting a positive charge on anionic RB
(Shrestha and Kishen, 2012; Shrestha et al., 2012). This conjugate
was evaluated against Enterococcus faecalis and Pseudomonas
aeruginosa biofilms, whereby its efficacy was compared to RB
and MB. Biofilms were cultured for 7 days, incubated for
15min with the respective PS at concentrations of 0.3mg/ml
(CSRB) or 10μM (RB, MB) and irradiated by 540 nm (CSRB,
RB) or 660 nm (MB) fibers. Applying a light dose of 40 J/cm2
resulted in inactivation rates of about 3 log10 steps for MB in
both biofilms, while for RB there were reductions of 3 log10
steps in Pseudomonas aeruginosa biofilms and 4 log10 steps in
Enterococcus faecalis biofilms. In contrast, when using CSRB
there was an inactivation of 9 log10 steps of Pseudomonas aerug-
inosa and 5 log10 steps of Enterococcus faecalis. The authors
explained these strikingly better results of CSRB compared to
anionic RB and cationic MB due to the greater ability of
CSRB to adhere to bacterial cells and the synergistic antibac-
terial effects of chitosan and RB (Shrestha and Kishen, 2012)
(Table 3).
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CURCUMIN, PERINAPHTHENONE AND FULLERENE DERIVATIVES
Recently, new classes of PS have been introduced as PS for
aPDT: Curcumins, perinaphthenone derivatives and fullerenes
(see Figure 5).
Curcumin [1E,6E-1,7-bis(4-hydroxy-3-methoxyphenyl)-1,6-
heptadiene-3,5-dione] is a naturally occurring intense-yellow
dye, isolated from the rootstocks of the plant Curcuma longa,
which has been used as medicine, spice and food-colorant for
hundreds of years (Crivello and Bulut, 2005; Aggarwal et al.,
2007). As its absorption spectrum is in the UV/blue wavelength
range (300–500 nm with a maximum at 430 nm), it has been
thought to be a feasible PS for aPDT (Araújo et al., 2012).
However, curcumin is a nearly quantitative type I mechanism PS,
whose photodynamic effect is due to hydrogen peroxide without
generation of singlet oxygen (Dahl et al., 1989).
Araújo et al. (2014) evaluated the susceptibility of Streptococcus
mutans and Lactobacillus acidophilus, either grown in multi-
species biofilms or in artificial dentine carious lesions, toward
aPDT with a curcumin-solution (consisting of 66.7% glucamin,
17.8% curcumin, 15.5% demethoxy and bisdemethoxy curcumin;
concentration: 0.75 to 5 g/l). Biofilms were cultured for 7 days,
exposed to the curcumin-solution for 5min and irradiated for
FIGURE 5 | Curcumin, perinaphthenone and fullerene derivatives.
Chemical structures of curcumin, perinaphthenone and fullerene
derivatives: (A) Curcumin. (B) PNS. (C) SAPYR. (D) Fullerene C60.
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5min with blue light derived from a LED (central wavelength:
450 nm; light dose: 5.7 J/cm2). With curcumin-concentrations
above 3 g/l, CFU were reduced by more than 3 log10 steps in
the multispecies biofilms. However, when the dentine carious
lesion was exposed to curcumin (5 g/l) with subsequent irradi-
ation, there was only a small reduction of 69%; this reduced
effect on bacteria located in demineralized dentine was explained
by the authors due to decreased penetration depth of the PS,
diminished binding to bacterial cells or attenuated penetration of
light (Araújo et al., 2014).
In contrast to curcumins, perinaphthenones are only slight
yellowish and exhibit singlet oxygen quantum yields close to
unity, therefore acting nearly exclusively according to type II
mechanism. Consequently, PNS (1H-phenalen-1-one-2-sulfonic
acid), which was the first derivative of perinaphthenone being
employed as a PS (originally described by Nonell et al., 1993), has
been proposed as a universal standard for singlet oxygen stud-
ies (Oliveros et al., 1999). However, PNS is negatively charged,
whereas positively charged PS are essential for good antimicrobial
activity (Alves et al., 2009). Therefore, recently SAPYR [2-((4-
pyridinyl)methyl)-1H-phenalen-1-one chloride] was introduced
as the lead compound of a batch of positively charged deriva-
tives based on a 7-perinaphthenone-structure, eliminating the
drawback of PNS, but conserving the high singlet oxygen quan-
tum yield of  0.99 (Cieplik et al., 2013b; Späth et al.,
2014). Our group evaluated SAPYR for its anti-biofilm properties
against Enterococcus faecalis and Actinomyces naeslundii grown in
monospecies or in polyspecies biofilms consisting of Enterococcus
faecalis, Actinomyces naeslundii, and Fusobacterium nucleatum
(Cieplik et al., 2013b). These biofilms were cultured for 72 h,
afterwards incubated for 60min with the respective PS at 100μM
(TMPyP served as a reference PS) and irradiated for 120 s with
a blue LED, usually applied for polymerization of dental resins
(light intensity at sample-level: 600mW/cm2). This light source
was used, as it is widely applied in dental practice, although its
emission spectrum shows only partial overlap with the absorption
spectra of SAPYR and TMPyP. Nevertheless, aPDT with SAPYR
resulted in CFU-reductions of more than 5 log10 for Enterococcus
faecalis in both types of biofilm; Actinomyces naeslundii was inac-
tivated by more than 2 log10 in monospecies and by more than
4 log10 in polyspecies biofilms. In contrast, as mentioned above
(Section Porphyrins, Chlorins, and Phthalocyanines), TMPyP
had no effect at all (Cieplik et al., 2013b).
As a completely distinct class of PS, fullerenes are ball-
shaped cage molecules composed of carbon atoms, whereby
fullerene C60 has to be regarded as the most studied com-
pound (Sharma et al., 2011). Recently, the group of Michael
R. Hamblin introduced several functionalized cationic fullerenes
as PS for aPDT, which showed notable results in vitro against
planktonic bacteria and yeasts (Mizuno et al., 2011). These com-
pounds absorb extensively in the visible and UV wavelength
range (Sharma et al., 2011) and react—in contrast to peri-
naphthenone derivatives—predominantly according to type I
mechanism, thus producing mainly superoxide (Mizuno et al.,
2011). However, until now fullerenes have not been tested
for their antimicrobial photodynamic efficacy against biofilms
(Table 4).
SYNOPSIS
All above-mentioned studies have in common that they are dif-
ficult to compare with each other. In general, with respect to
biofilm cultivation, different culture protocols with varying cul-
ture periods lead to different biofilms at distinct stages of devel-
opment. This is a general problem, which has not been solved
yet. While for testing a given antimicrobial against planktonic
cultures, MIC (minimal inhibitory concentration), and MBC
(minimal bactericidal concentration) assays are standardly used,
protocols or assays for testing antimicrobials in biofilm models
(e.g., the Calgary BiofilmDevice described by Ceri et al., 1999) are
not in widespread use. Consequently, the effect of a given PS on
24 h old biofilms described in one study can hardly be compared
to the effect of the same PS on 4 weeks old biofilms described in
another study. The ASM stated in 2010 that every new approach
has to reach a 3 log10 step reduction rate of CFU before being
able to use the terms “antimicrobial” or “antibacterial,” where-
fore CFU assays are mandatory for testing PS for aPDT against
biofilms. However, it has to be considered that it is a critical point
to disaggregate bacteria from a biofilm before doing a classical
CFU assay. Therefore, Live/Dead staining would be a suitable add-
on tool for confirmation of results. Live/Dead staining cannot be
used as the only evaluation method, though, as it only yields rel-
ative fluorescence counts without making an exact quantification
possible.
Another point is that in most studies, which deal with inacti-
vation of biofilms, the presence of an EPS has not been experi-
mentally verified (e.g., by fluorescence microscopy), although—
according to the general definition of a biofilm—this has to
be regarded as a major criterium for using the term “biofim”
(Donlan and Costerton, 2002). Consequently, in some cases the
“biofilms” usedmay not be true biofilms, but rather attached bac-
teria without any EPS. Therefore, the robustness, reproducibility
and relevance of the distinct biofilm assays, which were applied
in the studies discussed above, remain debatable. In addition, it
has to be considered that there is a remarkable difference between
in vitro biofilms and biofilms formed in vivo on tooth or mucosal
surfaces in the oral cavity. These clinical biofilms consist of hun-
dreds of bacterial and fungal species obtaining a thickness of
1000μm at least (Teixeira et al., 2012), whereas under labora-
tory conditions it is not able to mimic such complex biofilms.
Nevertheless, from the studies implied in this review it can be
concluded that there are not necessarily differences in inacti-
vation rates between bacterial and fungal biofilms or between
monospecies and polyspecies biofilms. In contrast, as shown by
Teixeira et al. and also by our group, the thickness of an in vitro
biofilm and its amount of EPS affect the efficacy of photodynamic
inactivation, which may be due to the inability of a PS to diffuse
throughout the entire biofilm (Teixeira et al., 2012; Cieplik et al.,
2013b).
From a photophysical point of view, it is also problematic
to compare the efficacy of two distinct PS on identically cul-
tured biofilms, as absorption characteristics may vary for every
PS. Therefore, the overlaps of two distinct PS with the emis-
sion of the same light source, thus the absorbed energies, can
differ vastly even if the applied energies are equivalent. For
example, this was shown by our group for TMPyP and SAPYR,
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where the total absorbed energies were 12.5 J for SAPYR vs. 80 J
for TMPyP, while the applied energies were matching (Cieplik
et al., 2013b). Giving the example of MB and SAPYR, different
light sources have to be used, as MB is activated by red light,
whereas SAPYR absorbs in the blue spectral range. Consequently,
it is not reasonable to directly compare efficacy rates, which
were revealed for a given PS in studies published by different
groups.
Furthermore, for evaluation of the antimicrobial properties of
a given PS it is essential to include appropriate control groups in
the experimental protocol. Typically, in so-called negative con-
trols, samples are treated either with PS only (PS+L-) or with
light only (PS-L+) or remain completely untreated (PS-L). In
contrast, positive controls mean that the efficacy of aPDT with
a respective PS is compared to that of a drug, which has already
demonstrated to exhibit pronounced antimicrobial properties; in
dentistry, suitable drugs for positive control groups would be
CHX or NaOCl. However, out of 22 studies reviewed in this
paper, only one (Meire et al., 2012) used an antimicrobial drug
(NaOCl) as a positive control. However, in this study no reagent
was used for stopping the activity of NaOCl after the respective
immersion period (Meire et al., 2012). It has to be considered that
the treatment periods of suchlike antimicrobials are difficult to
restrict when no reagents for stopping their antimicrobial effect
are used, whereas in contrast the effect of aPDT is stopped imme-
diately when the light is turned off, which reduces comparability
between these approaches. For example, Hecker et al. showed
that treatment with 1.0% and 3.0% NaOCl only had a biologi-
cally relevant effect (≥3 log10) on planktonic Enterococcus faecalis,
which was grown in artificially infected bovine root canals, when
the antimicrobial action of NaOCl was not arrested by adding
sodium thiosulfate after the respective treatment period (30, 60,
or 600 s). In contrast, when sodium thiosulfate was added, no bio-
logically relevant effect (≥3 log10) could be observed. Therefore,
the authors concluded that blocking the antimicrobial effect of a
given antimicrobial after the required treatment period is essen-
tial for laboratory testing in order to avoid distorting results
due to a prolonged action of the respective drug (Hecker et al.,
2013).
All in all, the findings reviewed in the present paper imply that
aPDT is an effective approach for inactivation of biofilms formed
in vitro. Concerning the situation in the oral cavity, these in vitro
results are promising for an application of aPDT as a supportive
antimicrobial tool to combat biofilm-associated infections in vivo.
Oral infections such as periodontal, endodontic or mucosal infec-
tions, and more recently periimplantitis represent—beside der-
mal infections—a superior field for application of aPDT due to
their localized nature. Nevertheless, until now clinical oral appli-
cation of aPDT is still in its infancy; clinical studies on aPDT
weremainly conducted with phenothiazinium derivatives likeMB
and TBO as PS examining the potential of the photodynamic
approach as a supportive tool for treatment of periodontitis, peri-
implantitis, or endodontic infection, whereby the results of these
studies are quite conflicting (Gursoy et al., 2013). Moreover, using
these PS, the patients’ aesthetic may get compromised due to the
strong blue color of these PS. For example, in periodontal appli-
cation the oral soft tissues may get stained bluish for at least a few
hours after treatment (Hayek et al., 2005; Sorkhdini et al., 2013).
When used in endodontics, even persistent blue staining of den-
tal structure via diffusion of the PS into dentinal tubules may get
induced, by what a further decoloration step using appropriate
chemical compounds may get necessary (Carvalho et al., 2011).
Although there is current research on developing only slightly or
even tooth-like colored PS, e.g., perinaphthenone derivatives like
SAPYR (Cieplik et al., 2013b; Späth et al., 2014), further clinical
research is needed—particularly on these new PS—for employing
aPDT regularly in dental practice.
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